Trevi Therapeutics (TRVI) Invested Capital (2021 - 2023)
Trevi Therapeutics (TRVI) posted quarterly Invested Capital of $153000.0 for Q4 2023, down 97.81% year-over-year from $7.0 million in Q4 2022, and down 97.96% quarter-over-quarter from $7.5 million in Q1 2023.
Trevi Therapeutics (TRVI) Invested Capital (2021 - 2023) Analysis & Trends
Trevi Therapeutics' Invested Capital history runs 3 years deep, the most recent figure standing at $153000.0 for Q4 2023.
- In Q4 2023, Invested Capital fell 97.81% year-over-year to $153000.0; the TTM figure through Sep 2024 stood at $153000.0 (down 98.94% YoY), while the FY2023 annual figure was $153000.0, down 97.81% from the prior year.
- Invested Capital for Q4 2023 stood at $153000.0, down from $7.5 million in the prior quarter.
- The five-year high for Invested Capital was $7.5 million in Q1 2023, with the low at $153000.0 in Q4 2023.
- The 3-year median for Invested Capital is $6.4 million (2021), against an average of $4.8 million.
- The sharpest annual moves came in 2022 and 2023: Invested Capital jumped 1100.69% in 2022, then plunged 97.81% in 2023.
- Trevi Therapeutics' Invested Capital stood at $5.8 million in 2021, then advanced by 20.01% to $7.0 million in 2022, then slumped by 97.81% to $153000.0 in 2023.
- Business Quant data shows TRVI's Invested Capital at $153000.0 in Q4 2023, $7.5 million in Q1 2023, and $7.0 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 190.90 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.57 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 380.00 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Trevi Therapeutics | 2.63 Bn | 2.63 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 153,000.00 |
| Mar 31, 2023 | 7.48 Mn |
| Dec 31, 2022 | 7.00 Mn |
| Sep 30, 2022 | 7.00 Mn |
| Jun 30, 2022 | 7.00 Mn |
| Mar 31, 2022 | 7.00 Mn |
| Dec 31, 2021 | 5.83 Mn |
| Sep 30, 2021 | 4.08 Mn |
| Jun 30, 2021 | 2.33 Mn |
| Mar 31, 2021 | 583,000.00 |